glp-1 agonist and dpp-4 inhibitor DPP4 Inhibitors vs Agonists | June 2021 | Clinical Corner It's the first in a
Description
Clinical Diabetes, 42 (1), 7486
The study period on medication or placebo following the lifestyle intervention is 72 weeks (84)
69705-5/asset/079012c9-a24f-4391-ba39-2f5d03668f6f/main.assets/gr1_lrg.jpg)
Theyre serious medications with strict usage requirements that are intended for chronic weight management." Researchers have also raised concerns that GLP-1 receptor agonists could be linked to more serious illnesses

Back Brown, JC, Magee, DF (Feb 1967) 'Inhibitory action of cholecystokinin on acid secretion from Heidenhain pouches induced by endogenous gastrin', Gut , 8/1, 29-31

It causes a variety of uncomfortable or painful symptoms, and can be dangerous in severe cases
